151 related articles for article (PubMed ID: 34861571)
21. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
[TBL] [Abstract][Full Text] [Related]
22. Trends of Opioid Use Disorder Among Hospitalized Patients With Chronic Pain.
Orhurhu V; Olusunmade M; Urits I; Viswanath O; Peck J; Orhurhu MS; Adekoya P; Hirji S; Sampson J; Simopoulos T; Jatinder G
Pain Pract; 2019 Jul; 19(6):656-663. PubMed ID: 31077526
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Rural-Urban Differences in Health Care Use and Survival Among Medicare Beneficiaries With Alzheimer Disease and Related Dementia.
Rahman M; White EM; Thomas KS; Jutkowitz E
JAMA Netw Open; 2020 Oct; 3(10):e2022111. PubMed ID: 33090226
[TBL] [Abstract][Full Text] [Related]
24. Urban-Rural Disparities in Opioid Use Disorder Prevention and Response Activities: A Cross-Sectional Analysis.
Swann WL; Kim S; Kim SY; Schreiber TL
J Rural Health; 2021 Jan; 37(1):16-22. PubMed ID: 32639664
[TBL] [Abstract][Full Text] [Related]
25. Spillover of Medicaid Expansion to Prescribing of Opioid Use Disorder Medications in Medicare Part D.
Abraham AJ; Lawler EC; Harris SJ; Bagwell Adams G; Bradford WD
Psychiatr Serv; 2022 Apr; 73(4):418-424. PubMed ID: 34407628
[TBL] [Abstract][Full Text] [Related]
26. Comparing state, regional, and local variation in concurrent opioid and benzodiazepine use.
Hernandez I; He M; Zhang Y
Drug Alcohol Depend; 2018 Oct; 191():141-144. PubMed ID: 30099175
[TBL] [Abstract][Full Text] [Related]
27. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
[TBL] [Abstract][Full Text] [Related]
28. The association of Medicare Part D prior authorization for buprenorphine-naloxone with adherence to opioid use disorder treatment guidelines in the United States.
Parish WJ; Mark TL; Zarkin GA; Weber E
Addiction; 2022 Jan; 117(1):141-150. PubMed ID: 34033177
[TBL] [Abstract][Full Text] [Related]
29. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
30. Association of Formulary Exclusions and Restrictions for Opioid Alternatives With Opioid Prescribing Among Medicare Beneficiaries.
Rao T; Kiptanui Z; Dowell P; Triebwasser C; Alexander GC; Harris I
JAMA Netw Open; 2020 Mar; 3(3):e200274. PubMed ID: 32119095
[TBL] [Abstract][Full Text] [Related]
31. Trends in prior receipt of prescription opioid or adjuvant analgesics among patients with incident opioid use disorder or opioid-related overdose from 2006 to 2016.
Wei YJ; Chen C; Schmidt SO; LoCiganic WH; Winterstein AG
Drug Alcohol Depend; 2019 Nov; 204():107600. PubMed ID: 31586806
[TBL] [Abstract][Full Text] [Related]
32. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
33. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019".
Krawczyk N; Rivera BD; Jent V; Keyes KM; Jones CM; Cerdá M
Int J Drug Policy; 2022 Dec; 110():103786. PubMed ID: 35934583
[TBL] [Abstract][Full Text] [Related]
34. Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults.
Adams ZW; Taylor BG; Flanagan E; Kwon E; Johnson-Kwochka AV; Elkington KS; Becan JE; Aalsma MC
J Adolesc Health; 2021 Aug; 69(2):321-328. PubMed ID: 33579622
[TBL] [Abstract][Full Text] [Related]
35. Quality of life in older adults with opioid use disorder: A scoping review.
Mackiewicz M; Brown RE; Price ET; Sargent L
Geriatr Nurs; 2022; 46():118-124. PubMed ID: 35679697
[TBL] [Abstract][Full Text] [Related]
36. Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.
Bagley SM; Chavez L; Braciszewski JM; Akolsile M; Boudreau DM; Lapham G; Campbell CI; Bart G; Yarborough BJH; Samet JH; Saxon AJ; Rossom RC; Binswanger IA; Murphy MT; Glass JE; Bradley KA;
Addict Sci Clin Pract; 2021 Jul; 16(1):46. PubMed ID: 34233750
[TBL] [Abstract][Full Text] [Related]
37. Trends in Opioid Use Disorder Among Older Adults: Analyzing Medicare Data, 2013-2018.
Shoff C; Yang TC; Shaw BA
Am J Prev Med; 2021 Jun; 60(6):850-855. PubMed ID: 33812694
[TBL] [Abstract][Full Text] [Related]
38. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
[TBL] [Abstract][Full Text] [Related]
39. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
[TBL] [Abstract][Full Text] [Related]
40. Impact of reported NSAID "allergies" on opioid use disorder in back pain.
Li L; Chang Y; Song S; Losina E; Costenbader KH; Laidlaw TM
J Allergy Clin Immunol; 2021 Apr; 147(4):1413-1419. PubMed ID: 32916184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
